DD151063A5 - Verfahren zur herstellung von phenothiazinderivaten - Google Patents

Verfahren zur herstellung von phenothiazinderivaten Download PDF

Info

Publication number
DD151063A5
DD151063A5 DD80220806A DD22080680A DD151063A5 DD 151063 A5 DD151063 A5 DD 151063A5 DD 80220806 A DD80220806 A DD 80220806A DD 22080680 A DD22080680 A DD 22080680A DD 151063 A5 DD151063 A5 DD 151063A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
phenothiazine
imidazolyl
acid
oxide
Prior art date
Application number
DD80220806A
Other languages
German (de)
English (en)
Inventor
Joachim Gante
Hans-Eckart Radunz
Dieter Orth
Hans-Jochen Schliep
Ernst Schorscher
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of DD151063A5 publication Critical patent/DD151063A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DD80220806A 1979-05-02 1980-04-30 Verfahren zur herstellung von phenothiazinderivaten DD151063A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792917650 DE2917650A1 (de) 1979-05-02 1979-05-02 Phenothiazinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD151063A5 true DD151063A5 (de) 1981-09-30

Family

ID=6069737

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80220806A DD151063A5 (de) 1979-05-02 1980-04-30 Verfahren zur herstellung von phenothiazinderivaten

Country Status (19)

Country Link
US (1) US4289768A (fi)
EP (1) EP0018542B1 (fi)
JP (1) JPS55147280A (fi)
AR (1) AR227640A1 (fi)
AT (1) ATE2673T1 (fi)
AU (1) AU533392B2 (fi)
CA (1) CA1135263A (fi)
CS (1) CS222690B2 (fi)
DD (1) DD151063A5 (fi)
DE (2) DE2917650A1 (fi)
ES (1) ES491048A0 (fi)
FI (1) FI801397A (fi)
HU (1) HU181702B (fi)
IE (1) IE50177B1 (fi)
IL (1) IL59972A (fi)
NO (1) NO801255L (fi)
PL (1) PL122711B2 (fi)
SU (1) SU867309A3 (fi)
ZA (1) ZA802629B (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112358475B (zh) * 2020-11-30 2022-09-06 西北师范大学 一种苯并吡喃鎓-吩噻嗪衍生物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2591679A (en) * 1952-04-08 Aminoalkanoyl phenothiazine deriv
FR1488281A (fr) * 1966-03-29 1967-07-13 Chimetron Sarl Benzimidazoles portant un substituant dérivé de la phénothiazine

Also Published As

Publication number Publication date
FI801397A (fi) 1980-11-03
HU181702B (en) 1983-11-28
AU5797280A (en) 1980-11-06
PL122711B2 (en) 1982-08-31
AU533392B2 (en) 1983-11-24
SU867309A3 (ru) 1981-09-23
IL59972A (en) 1983-10-31
IL59972A0 (en) 1980-07-31
ES8200364A1 (es) 1981-11-01
CS222690B2 (en) 1983-07-29
US4289768A (en) 1981-09-15
EP0018542A1 (de) 1980-11-12
ZA802629B (en) 1981-05-27
EP0018542B1 (de) 1983-03-02
IE50177B1 (en) 1986-03-05
IE800886L (en) 1980-11-02
NO801255L (no) 1980-11-03
PL223898A2 (fi) 1981-02-13
JPS55147280A (en) 1980-11-17
DE2917650A1 (de) 1980-11-13
AR227640A1 (es) 1982-11-30
CA1135263A (en) 1982-11-09
ES491048A0 (es) 1981-11-01
DE3062170D1 (en) 1983-04-07
ATE2673T1 (de) 1986-03-15

Similar Documents

Publication Publication Date Title
DE69909818T2 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
EP0080602A1 (de) Substituierte Benzimidazole, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel
DE2846945A1 (de) Pharmazeutische praeparate
DE4237656A1 (de) Benzimidazolderivate
DE3505609A1 (de) Benzimidazolyl-pyridazinone
DD265403A5 (de) Verfahren zum herstellen herzstimulierender chinolene
EP0410208A1 (de) Chromanderivate
EP0214479A2 (de) Benzimidazol-2-yl-pyridiniumverbindungen
DE2906252A1 (de) Pyrazolderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
DE3509333A1 (de) Substituierte benzimidazolderivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
DD151063A5 (de) Verfahren zur herstellung von phenothiazinderivaten
DE2321518A1 (de) Neue sulfamylbenzoesaeurederivate
DE1695515A1 (de) Aromatische Sulfoxide und Verfahren zu deren Herstellung
EP0683776B1 (de) Substituierte heteroarylalkylthiopyridine zur bekämpfung von helicobacter bakterien
DE3819037A1 (de) 2,4-disubstituierte oxazol-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als therapiemittel gegen krankheiten, die durch rhinoviren verursacht werden
EP0110298B1 (de) Acridanon-Derivate
DE2805167A1 (de) Entzuendungshemmende imidazole, verfahren zu ihrer herstellung und sie entheltende arzneimittel
EP0672660B1 (de) Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate
EP0371312B1 (de) Benzoxazinderivate
DE2234258A1 (de) Heterocyclische substituierte xanthoncarbonsaeureverbindungen
EP0111205B1 (de) Acridanon-Derivate
DE19653024A1 (de) Endothelin-Rezeptor-Antagonisten
DE3832848A1 (de) Benzothiophen-2-carboxamid-s,s-dioxide
DD237509A5 (de) Verfahren zur herstellung von 2-(1h)-chinolonen
DE4235603A1 (de) Arylalkoxythiocumarine, Verfahren zu ihrer Herstellung und diese enthaltende therapeutische Mittel